Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

360 Finance Stock: Generous Dividend Amid Persistent Downtrend

Robert Sasse by Robert Sasse
September 2, 2025
in Analysis, Asian Markets, Crypto Stocks, Dividends, Earnings
0
360 Finance Stock
0
SHARES
269
VIEWS
Share on FacebookShare on Twitter

Shares of 360 Finance (Qfin Holdings) are approaching a significant dividend distribution while continuing to trade beneath critical technical levels. The company’s latest quarterly results delivered a mixed performance, ultimately triggering a sharp sell-off in the stock.

Technical Weakness Prevails

The stock is currently trading around $29.12, positioning it well below its key moving averages and confirming a sustained bearish trend.

  • 50-day moving average: $37.34
  • 200-day moving average: $40.31

Trading volume of 1.4 million shares last Friday also remained below the average of 2.19 million, a pattern often seen in the period preceding a dividend event.

Mixed Q2 Earnings and a Dismal Forecast

The Q2 2025 financial report presented solid fundamental results but was ultimately overshadowed by a disappointing forward outlook.

  • Total net revenue: RMB 5.22 billion (approx. $728 million)
  • Net income: RMB 1.73 billion (approx. $241.6 million)
  • Total loan facilitation growth: +16.1% year-over-year

The positive figures were quickly negated by management’s guidance, which projects a quarter-over-quarter decline in EPS between 2.7% and 14% for Q3. This pessimistic forecast precipitated a 12% plunge in the share price following the announcement.

Should investors sell immediately? Or is it worth buying 360 Finance?

Substantial Dividend Payout Approaches

Despite the negative price action, shareholders have a substantial capital return to anticipate. The FinTech company has declared a semi-annual cash dividend of $0.38 per ordinary share, or $0.76 per ADS (American Depositary Share). This translates to an attractive annualized dividend yield of 5.22%.

  • Ex-dividend date: September 8, 2025
  • Payment date for ordinary shares: September 25, 2025
  • Approximate payment date for ADS: September 30, 2025

This consistent return of capital to investors highlights the company’s continued ability to generate robust cash flows.

Divergent Views from Analysts

Market experts are divided on the stock’s prospects. JPMorgan maintains a bullish “Overweight” rating with a $65 price target. In contrast, Wall Street Zen recently downgraded its recommendation from “Buy” to “Hold.” The consensus price target stands at $51.73, suggesting significant potential upside from current levels, though the weak guidance casts doubt on this optimism.

Institutional Investors Show Discord

Institutional ownership remains high at 74.81% of shares, but recent activity points to significant disagreement among major funds. American Century Investments decreased its stake by 17.8%, while Mirae Asset Global Investments dramatically increased its position by an astounding 10,812.1%. HSBC also sold 23,072 shares. These conflicting moves reflect broader uncertainty regarding the future trajectory of the FinTech sector.

The central question for investors is whether the appeal of the high dividend yield will be enough to offset concerns driven by the company’s gloomy earnings forecast.

Ad

360 Finance Stock: Buy or Sell?! New 360 Finance Analysis from February 7 delivers the answer:

The latest 360 Finance figures speak for themselves: Urgent action needed for 360 Finance investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

360 Finance: Buy or sell? Read more here...

Tags: 360 Finance
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

February 7, 2026
Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock
Earnings

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Next Post
Lightwave Logic Stock

Lightwave Logic Shares Exhibit High Volatility Amid Mixed Performance Signals

MSCI World ETF Stock

The Hidden Concentration Risk in a Popular Global ETF

Kopin Stock

Kopin Appoints New Finance Chief Amid Strategic Pivot

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com